| Drug Name |
Bilastine |
| Drug ID |
BADD_D02615 |
| Description |
Bilastine is a novel new-generation antihistamine that is highly selective for the H1 histamine receptor, has a rapid onset and prolonged duration of action. |
| Indications and Usage |
For symptomatic relief of nasal and non-nasal symptoms of seasonal rhinitis in patients 12 years of age and older and for symptomatic relief in chronic spontaneous urticaria in patients 18 years of age and older [FDA Label]. |
| Marketing Status |
approved; investigational |
| ATC Code |
R06AX29; S01GX13 |
| DrugBank ID |
DB11591
|
| KEGG ID |
D09570
|
| MeSH ID |
C445659
|
| PubChem ID |
185460
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
42765-045 |
| UNII |
PA1123N395
|
| Synonyms |
bilastine |
